Sponsors

The TTS Global Initiative Sponsors

International Development Opportunities for Partners 2012-2013

The TTS Global Initiative is a unique international network and community of key biotechnology sector technology transfer and innovation professionals, leading researchers, early stage SMEs, C-level biotech executives, corporate licensing and business development executives, serial entrepreneurs, VC, corporate and angel investors, bioregion and science park executives. These key stakeholders are all working to commercialize the ever-increasing amount of innovative biotechnology in our society. The Summits facilitate these efforts by providing:

  • an interlinked global networking platform of key stakeholders and innovators, for the dissemination and deliberation of challenges and solutions,
  • an exchange of knowledge and best practices,
  • a review of current methods and processes, and ultimately
  • access to business resources that stimulate and instigate the commercialization of innovative technology.

The TTS Global Initiative is of crucial value to; Big Pharma, C-level biotech executives, early stage SMEs, entrepreneurs, patent advisors, IP law firms, Tech Transfer specialists, academic researchers & innovators, University Tech Transfer Offices, research institutes, national and multinational corporations, and VC and corporate investors alike.

The Summits provide an environment that is conducive to; successful networking, launching collaborations, and sourcing, industry partners for in- and out-licensing opportunities, investors and IP specialists to form partnerships that can help drive forward innovative technologies to the commercial markets.

Worldwide, there is no other major initiative that focuses so effectively on this sector and brings so many key representatives together from research and industry. Nor is there any other initiative, which brings key innovation stakeholders in the biotech sector together in such a unique, efficient and constructive format. The TTS Global Initiative is the ultimate platform for targeting decision makers in your key market.

The TTS Global Initiative is co-sponsored and hosted by some of the most important research and innovation funding agencies in the world, and a limited number of Official Partner Opportunities are available.   

The opportunity for Partners remains exceptional. Ensure that your organization is at the forefront of the leading international platform uniting the technology managers and gatekeepers of the world’s best public sector research with Industry Licensing Executives and other top experts from the world of biotech transfer, partnering, licensing, IP and venture.

The 2012 – 2013 TTS Global Initiative includes:

  • The TTS Europe: 25 -26 June 2012 at the Pasteur Institute in Paris, France. Co-Hosted by Inserm Transfert (Technology Transfer Division of the French Institute for Health & Medical Research), the Pasteur Institute, AVIESAN (French National Alliance for Life Sciences & Health), and with the Support of the European Commission, Leading Big Pharma, Venture Capital, ASTP (Association of Science & Technology Professionals), and Europe’s key biotech and bio-pharma associations.
  • The TTS North America: 22-23 October 2012 at Johns Hopkins University, Montgomery County Campus, Maryland.  Co-Hosted by the National Institutes of Health (NIH), BioMaryland, Maryland Biotechnology Center, Montgomery Country, and Johns Hopkins Technology Transfer, with the support of leading Big Pharma, Venture Capital, BIO (Biotechnology Industry Organization), LES (Licensing Executive Society), and other key industry and partners.
  • The TTS Australia: Melbourne, Australia, in August/September 2013 (dates subject to final confirmation) 

The TTS Global Initiative addresses the most crucial and fundamental needs of the biotechnology sector, providing in particular an early stage platform for rapid progress, as well as gathering together key participants and stakeholders that can return real value to both institutions and companies. The most important meeting of the year for biotech and healthcare focused TTOs, universities, park and bioregion innovation managers, and pharma Collaborative R&D and licensing executives. Un-matched expertise, an informative and interactive atmosphere, and the chance to meet, build networks and relationships with, learn from and do business with the leading industry executives representing the potential buyers of their science. In addition many of the most important specialized investors, and the leading experts and advisors in the field will be present.

There is no other initiative which focuses so directly on the key challenge of creating a vibrant biotechnology sector through the realization and capture of the inherent value of world-class research. It is proving to be without equal as a biotech business forum for meeting key people and developing critical contacts and relationships to move any biotech business or project forward. Secure your position as a key Partner of the TTS Global Initiative, at the forefront of discussions that matter most to these high caliber participants.

Simply put, senior representatives from the complete biotech value chain, the important decision-makers, all in one place.

Opportunities and access to the Summits are limited.

Secure Partner status for your company, firm or organization now, and ensure that you have access to the exclusive platform provided by the Summits that make up the TTS Global Initiative. 

Why become a Partner of the TTS Global Initiative™?

  • Outstanding access to the key innovations, innovators & stakeholders.
  • Exclusive access to the leading initiative of its type, a unique interlinked global community, network and platform.
  • Exclusive utilization of TTS’ secure repository of global technology offerings. Featuring critical offers from the leading life sciences research universities and institutes in the worldwide TTS community.
  • Extensive global marketing visibility. Recognition in all promotional materials, speaker bio on website, logo & Link from Summit(s) website(s).
  • Strategic on-site visibility as one of a limited number of key partners. Speaking role(s), inclusion in all on-site material, advertising in Summit binder, logo on posters, signs, projections, & more.
  • Build quality deal-flow and an un-matched global network. Identify cutting-edge science and develop R&D, licensing, collaboration, partnering & other business opportunities.
  • Develop relationships with top Tech Transfer Officers and their representative officers, and of course the innovators themselves.
  • Customizable branding opportunities.
  • VIP registrations

For more information or to become a Partner, please contact:

Christian J. Suojanen

Morris S. Berrie

 

TTS Ltd.

1 Highlever Road, London, W10 6PP, United Kingdom

(Registration: 06852240)

Sponsors & Partners:































Sponsors & Partners:

Ministry or Research & Higher Education


Sanofi


 



Cabinet Plasseraud


FaskenMartineau


CDC Entreprises


SATT Conectus Alasace


Inserm Transfert Initiative


ASTP


EuropaBio


EC Research & Innovation


Licensing Executive Society


EFPIA



ShareVault


Biotech Finances